These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19012060)

  • 1. Young women's use of a vaginal microbicide surrogate: the role of individual and contextual factors in acceptability and sexual pleasure.
    Tanner AE; Zimet G; Fortenberry JD; Reece M; Graham C; Murray M
    J Sex Res; 2009; 46(1):15-23. PubMed ID: 19012060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acceptability of vaginal microbicides among female sex workers in urban Beijing, China].
    Han L; Lv F; Zhang GL; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):136-8. PubMed ID: 19565872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
    Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M
    Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
    Hoel N; Shaikh S; Kagee A
    Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of microbicide acceptability among U.S. adolescent girls.
    Short MB; Perfect MM; Auslander BA; Devellis RF; Rosenthal SL
    Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal microbicide preferences among midwestern urban adolescent women.
    Tanner AE; Katzenstein JM; Zimet GD; Cox DS; Cox AD; Fortenberry JD
    J Adolesc Health; 2008 Oct; 43(4):349-56. PubMed ID: 18809132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
    J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women and sexually transmitted diseases.
    Leonardo C; Chrisler JC
    Women Health; 1992; 18(4):1-15. PubMed ID: 1462599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Woman-initiated methods for HIV prevention.
    Stein Z
    GMHC Treat Issues; 1997; 11(7-8):20-2. PubMed ID: 11364646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young Women's use of a microbicide surrogate: the complex influence of relationship characteristics and perceived male partners' evaluations.
    Tanner AE; Fortenberry JD; Zimet GD; Reece M; Graham CA; Murray M
    Arch Sex Behav; 2010 Jun; 39(3):735-47. PubMed ID: 19224355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
    Tanner AE
    SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's acceptance of the diaphragm: the role of relationship factors.
    Beckman LJ; Harvey SM; Thorburn S; Maher JE; Burns KL
    J Sex Res; 2006 Nov; 43(4):297-306. PubMed ID: 17599251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
    Mosack KE; Weeks MR; Novick Sylla L; Abbott M
    Women Health; 2005; 42(2):71-88. PubMed ID: 16537301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050).
    Carballo-Diéguez A; Balán IC; Morrow K; Rosen R; Mantell JE; Gai F; Hoffman S; Maslankowski L; El-Sadr W; Mayer K
    AIDS Care; 2007 Sep; 19(8):1026-31. PubMed ID: 17852000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covert use of topical microbicides: implications for acceptability and use.
    Woodsong C
    Perspect Sex Reprod Health; 2004; 36(3):127-31. PubMed ID: 15306271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.